Vaccine Hesitancy during the Coronavirus Pandemic—Lessons from Polio
The COVID-19 pandemic continues to cause disruptions to families, businesses and healthcare systems globally [...]
Guardado en:
Autores principales: | Lakshini Gunasekera, Tissa Wijeratne |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b568bb8cec3643afa166ae03470eef04 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Plant-made polio type 3 stabilized VLPs—a candidate synthetic polio vaccine
por: Johanna Marsian, et al.
Publicado: (2017) -
Biological and Clinical Significance of Adaptive Evolution of Coronaviruses
por: Apostolos Beloukas, et al.
Publicado: (2021) -
Salk Anti-Polio Vaccine
Publicado: (2017) -
Recommendations for acceleration of vaccine development and emergency use filings for COVID-19 leveraging lessons from the novel oral polio vaccine
por: Natalie Thiel, et al.
Publicado: (2021) -
Polio, approaching eradication as a result of vaccination
por: José A. Moreno-González, et al.
Publicado: (2021)